AI-enhanced echocardiography improves early detection of amyloid buildup in the heart – Mayo Clinic News Network
Mayo Clinic and Ultromics developed an AI model for highly accurate screening of cardiac amyloidosis, a rare and progressive heart failure. The FDA-cleared model, validated on a large, multiethnic population, boasts 85% sensitivity and 93% specificity, outperforming traditional methods. Early diagnosis is crucial due to available treatments, and this AI tool promises improved patient outcomes.
